Analysis of all mice treated with triple therapy, with or without LC, indicated a role for granzyme B+ and effector memory CD4+ and CD8+ T cells in the antitumor response (Fig. 1D; Supplementary Fig. S3B). The gene discussed is CD4; the disease is laryngotracheoesophageal cleft.